Description: This article describes a simple but powerful tool for use by valuation actuaries and auditors when evaluating current assumptions for use in GAAP net premium reserve methods that require retrospective updating for actual experience and assumption changes. As a supplement, this tool can fill some holes left by existing tools. It produces results that can be compared to materiality thresholds at any level of aggregation, from a single reserve cohort up to the combination of all cohorts for all products subject to retrospective net premium reserve requirements. It can also serve as a benchmarking tool for estimated the possible effects of an assumption change or to help in explaining the effects of an actual assumption change.

Description: Risk adjustment is needed under IFRS 17 to reflect the compensation that a company requires for bearing the uncertainty about the amount and timing of the cash flows that arises from non-financial risk. Companies are also required to disclose the method and confidence level used for the calculation of the RA. However, IFRS 17 doesn’t specify a method and a confidence level, nor does it provide a list of specific risks that are considered to be non-financial risk. Companies need to define them based on their own preferences or existing practices. This article will introduce available approaches and discuss the confidence level approach with potential consideration stemming from industry preferences and illustrative examples.

Description: This article is an update, as of September 2019, on projects in process and those recently completed.

Description: Feature article describing the status of research reports relevant to Financial Reporting Section members.

Description: The American Academy of Actuaries will present on current initiatives that impact the U.S. statutory reserving methodology for non-variable annuity contracts. In particular, the development of a principle-based reserving framework on non-variable annuity contracts will be discussed, including framework elements, assumptions, and methodology. The session will provide an update on the status of regulatory discussions and the timeline for future changes to reserves. By the end of the session, attendees will understand what changes are being made to non-variable annuity reserves, details underlying existing proposals, and the anticipated timing of such emerging changes. This session is intended to the meet the needs of actuaries focused on annuity reserve calculations, financial reporting, and valuation.

Description: In this session 100OF of the New York Annual Meeting panelists discuss the major consequences and potential effects of the current economic environment, including the choices of assumption that actuaries should consider in performing cash-flow testing. From the Record of the Society of Actuaries, Vol. 24, No. 3.

Description: In session 132 PD of the New York Annual Meeting panelists discuss the content and status of the draft NAIC Actuarial Guideline ZZZ and the work of the AAA Task Force on Variable Products with Guaranteed Living Benefits. The Black-Scholes option pricing method is also covered. From the Record of the Society of Actuaries, Vol. 24, No. 3.

Description: From session 75CS at the Spring regional meeting of the Society of Actuaries held in Atlanta, Georgia, May 24-25, 1999, Presenters identify issues and challenges faced by the valuation actuary when performing cash-flow testing on equity-indexed and variable products.

Description: From a session at the annual meeting of the Society of Actuaries held in Chicago, Illinois, October 15-18, 2000 Panelists discuss the changes these companies were making, the experience so far as a public company, and how investors are viewing them.

Description: This session from the 2003 SOA Orlando Meeting focuses on the actuary's role and responsibility in the financial reporting process. It covers peer-review standards in Canada, Sarbanes-Oxley and the implementation of both in financial reporting. From the Record of the Society of Actuaries, Volume 29, No. 3.